4-pentenoic acid

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1967-2018
024619672018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1995
1995
It is postulated that the hepatotoxicity of valproic acid (VPA) results from the mitochondrial beta-oxidation of its cytochrome… (More)
Is this relevant?
1993
1993
The terminal olefin metabolite of valproic acid (VPA), 4-ene VPA, is an analog of the experimental hepatotoxin 4-pentenoic acid… (More)
Is this relevant?
1989
1989
The covalent binding of radioactivity to protein following administration of 14C-labeled analogs of valproic acid (VPA) and a… (More)
Is this relevant?
1987
1987
The in vivo hepatic lipid peroxide content of rats was increased by aspirin or 4-pentenoic acid (4-PA) administration but was… (More)
Is this relevant?
1986
1986
A number of metabolites of the anticonvulsant drug valproic acid (VPA) as well as related substances were tested in regard to… (More)
Is this relevant?
1985
1985
The inhibition of carnitine acetyltransferase (EC 2.3.1.7) by metabolites of 4-pentenoic acid was studied. 3-Keto-4-pentenoyl-CoA… (More)
Is this relevant?
1985
1985
Valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid, were found to inhibit strongly the metabolism of… (More)
Is this relevant?
1983
1983
The metabolism of 4-pentenoic acid, a hypoglycemic agent and inhibitor of fatty acid oxidation, has been studied in rat heart… (More)
Is this relevant?
1976
1976
The growth of Tetrahymena pyriformis strain HSM was strongly inhibited by 4-pentenoic acid. Supplementing the medium acetate… (More)
Is this relevant?
1971
1971
The effects of 4-pentenoic acid on substrate oxidations and on the distribution of coenzyme A and its derivatives were studied in… (More)
  • figure 1
  • figure 2
  • table I
  • figure 4
  • figure 3
Is this relevant?